Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Imarc Group
www.imarcgroup.com/
Kanika Sharma
sales@imarcgroup.com
8130434268
GB Nagar
Nehru Complex

Bookmark and Share
Male Infertility Market Size to Hit $6.32B by 2033: Key Trends & Forecast
The global male infertility market size was valued at USD 4.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.32 Billion by 2033, exhibiting a CAGR of 4.51% during 2025-2033.

BriefingWire.com, 8/19/2025 - The global male infertility market size was valued at USD 4.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.32 Billion by 2033, exhibiting a CAGR of 4.51% during 2025-2033. 

Grab a sample PDF of this report: https://www.imarcgroup.com/male-infertility-market/requestsample

The global demand for male infertility solutions is rising, driven by higher infertility rates—currently affecting approximately 7% of men globally—and lifestyle factors such as stress, obesity, and environmental pollution. Increased awareness, delayed parenthood, and advanced diagnostics are further fueling the need for infertility treatments. Major companies have expanded their product portfolios, with diagnostic kits and ART (assisted reproductive technology) devices becoming more widely available in clinics and hospitals worldwide.

Government schemes and public health initiatives, like subsidized IVF programs and national fertility awareness campaigns, are enhancing access to male infertility treatments. In key markets, initiatives offer financial support for fertility diagnostics and therapies, broadening patient reach. Recent industry news highlights strategic collaborations between fertility clinics and biotechnology companies to enhance innovative treatments and improve clinical outcomes for male patients.

Key Market Trends & Insights:

Rise in Advanced Diagnostic Technologies

Innovative diagnostic methods like sperm DNA fragmentation analysis and magnetic-activated cell sorting (MACS) are gaining traction globally, allowing specialists to assess sperm quality with greater accuracy. DNA fragmentation techniques are now the largest segment by test type, offering precise molecular-level insights, and increasing the demand for accurate male infertility diagnostics.

Growth of Assisted Reproductive Technologies (ART)

Procedures such as intracytoplasmic sperm injection (ICSI) and testicular sperm extraction (TESE) are now widely used for severe male infertility. The widespread uptake of ART has significantly raised success rates, as seen in the launch of AI-powered platforms like SpOvum ARTPT, streamlining patient experience in ART clinics.

Emphasis on Delayed Parenthood Solutions

With more men opting to have children later due to changing societal norms and career goals, specialized fertility preservation and treatment options, including cryopreservation and tailored interventions for aging males, are increasingly sought. A majority of men over 40 are now directly seeking such treatments.

Integration of Fertility Services and Centers

Dedicated fertility centers are increasingly prominent, bringing together multi-disciplinary teams and advanced technology under one roof. These centers provide end-to-end services—diagnosis, tailored therapies, and ART—addressing the emotional and physiological needs of male infertility patients more effectively than ever.

Rise of Public Awareness and Preventive Measures

Broader awareness campaigns and government health initiatives have elevated public consciousness. In the US, rising obesity rates among men (over 39% prevalence) and lifestyle-linked infertility are spurring early screening and proactive interventions, supported by expanding insurance coverage for male infertility treatments.

Ask analyst of customized report: https://www.imarcgroup.com/request?type=report&id=6416&flag=E

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2025 Proserve Technology, Inc.